CMTA-STAR has awarded $354,826 to support a clinical trial evaluating L-serine in patients with Hereditary Sensory Neuropathy 1, a rare form of CMT. Led by Dr. Mary Reilly at University College London, the study will assess disease progression using MRI muscle fat fraction as a primary outcome measure, advancing clinical trial readiness for inherited neuropathies.
Alan Jackson shares his CMT story with the Today Show
This morning, country star Alan Jackson shared his journey with Charcot-Marie-Tooth disease on the Today...
